Global Lateral Flow Assay Market Size - Forecasts to 2026

According to a new market research report published by Global Market Estimates, the Global Lateral Flow Assay Market is projected to grow from USD 0.20 billion in 2021 to USD 0.24 billion by 2026 at a CAGR value of 8.0% from 2021 to 2026.

The use of lateral flow assays in the point-of-care medical field has gained a lot of momentum in the scientific community, which is driving the market for lateral flow assays. Furthermore, the high frequency of contagious illnesses, rapid expansion of the geriatric population, rising need for point-of-care diagnostic techniques, and increased use of home-based lateral flow assay instruments are all driving the market’s growth.

Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC on “Global Lateral Flow Assay Market - Forecast to 2026”

https://www.globalmarketestimates.com/market-report/lateral-flow-assay-market-3646

By Product Type (Kits & Reagents, Lateral Flow Readers), By Application (Clinical Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, Drug Development & Quality Testing), By Technique (Sandwich Assays, Competitive Assays, Multiplex Detection Assays), By Sample Type (Blood Samples, Urine Samples, Saliva Samples, Other Samples), By End-User (Hospitals & Clinics, Diagnostics Laboratories, Home Care Settings, Pharmaceuticals & Biotechnology Companies, Other End Users), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa), Company Market Share Analysis, and Competitor Analysis

Key Market Insights

  • As per the product type outlook, the kits & reagents segment is expected to grow the fastest in the market from 2021 to 2026.
  • The clinical testing segment is expected to be the largest segment in the market from 2021 to 2026 as per the application segmentation
  • Based on the end-user outlook, the hospitals & clinics segment is expected to be growing the fastest in the market from 2021 to 2026
  • North America (the United States, Canada, and Mexico) will have a dominant share in the Lateral Flow Assay market from 2021 to 2026
  • Abbott Laboratories, Hologic Inc., F.Hoffmann-La Roche, Danaher Corporation, Quidel Corporation, Thermo Fisher Scientific Inc., Siemens AG, Becton, Bio-Rad, PerkinElmer, Dickinson and Company, bioMerieux, among others are the key players in the lateral flow assay market

Browse the Report @ https://www.globalmarketestimates.com/market-report/lateral-flow-assay-market-3646

Product Type Outlook (Revenue, USD Billion, 2021-2026)

  • Kits & Reagents
  • Lateral Flow Readers

Application Outlook (Revenue, USD Billion, 2021-2026)

  • Clinical Testing
  • Veterinary Diagnostics
  • Food Safety & Environmental Testing
  • Drug Development & Quality Testing

Technique Outlook (Revenue, USD Billion, 2021-2026)

  • Sandwich Assays
  • Competitive Assays
  • Multiplex Detection Assays

Sample Type Outlook (Revenue, USD Billion, 2021-2026)

  • Blood Samples
  • Urine Samples
  • Saliva Samples
  • Other Samples

End-User Outlook (Revenue, USD Billion, 2021-2026)

  • Hospitals & Clinics
  • Diagnostics Laboratories
  • Home Care Settings
  • Pharmaceuticals & Biotechnology Companies
  • Other End Users

Regional Outlook (Revenue, USD Billion, 2021-2026)

North America

  • The U.S.
  • Canada
  • Mexico

Europe

  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Rest of APAC

Central & South America

  • Brazil
  • Argentina
  • Rest of CSA

Middle East & Africa

  • Saudi Arabia
  • UAE
  • Rest of MEA

Contact: Yash Jain

Email address: yash.jain@globalmarketestimates.com

Phone Number: +16026667238

Website: Global Market Estimates

Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php